HFA Premium Access

Upgrades from a previous device compared to de novo CRT implantation in the CRT Survey II: a European Society of Cardiology survey of cardiac resynchronization therapy in 11.088 patients


About the speaker

Professor Cecilia Linde

Karolinska Institutet, Stockholm (Sweden)
42 presentations
1 follower

11 more presentations in this session

Discussion - CRT Survey II


Long-term outcome in the pivotal MOMENTUM 3 trial: medical resource use and cost implications

Speaker: Professor M. Mehra (Boston, US)


Discussion - MOMENTUM 3


Cardiac contractility modulation improves peak VO2, long-term survival and hospitalisations in heart failure with reduced ejection fraction; evidence from FIX-5C and the EU registry

Speaker: Professor G. Hasenfuss (Goettingen, DE)


Discussion - FIX-5C and the EU registry


Access the full session

Late breaking trial III - Innovative and device therapy

Speakers: Professor C. Linde, Professor M. Mehra, Professor G. Hasenfuss

About the event


Heart Failure 2018 & World Congress on Acute Heart Failure

26 May - 29 May 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk